TRANSCODE THERAPEUTICS INC (RNAZ) Institutional Ownership Changes & 13F Activity
TRANSCODE THERAPEUTICS INC (RNAZ). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Geode Capital Management, Llc, Vanguard Capital Management Llc, Ubs Group Ag, Vanguard Fiduciary Trust Co, and Tower Research Capital Llc (Trc).
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Wells Fargo & Company/Mn | Buy | +55 | — | 55 | $474.00 | Q1 2026 | Jul 08, 2026 |
| Geode Capital Management, Llc | Buy | +12,740 | — | 12,740 | $109.69K | Q1 2026 | May 15, 2026 |
| Tower Research Capital Llc (Trc) | Sell | -659 | -74.3% | 228 | $1.96K | Q1 2026 | May 15, 2026 |
| Vanguard Capital Management Llc | Buy | +6,545 | — | 6,545 | $56.35K | Q1 2026 | May 08, 2026 |
| Vanguard Fiduciary Trust Co | Buy | +2,982 | — | 2,982 | $25.68K | Q1 2026 | May 08, 2026 |
| Ubs Group Ag | Buy | +5,331 | +179.9% | 8,295 | $71.42K | Q1 2026 | May 05, 2026 |
| Sbi Securities Co., Ltd. | Buy | +2 | +20.0% | 12 | $103.00 | Q1 2026 | Apr 28, 2026 |
| Bank Of America Corp | Sell | -8 | -100.0% | 0 | $0.00 | Q1 2026 | Feb 17, 2026 |
| Osaic Holdings, Inc. | Sell | -3 | -100.0% | 0 | $0.00 | Q1 2026 | Feb 17, 2026 |
Frequently asked questions about RNAZ activity
Which institutional owners are buying RNAZ?
Institutional owners buying RNAZ include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in RNAZ activity?
"Buy" means an investor increased their reported position in RNAZ compared to the prior reporting period. This reflects growing exposure to TRANSCODE THERAPEUTICS INC (RNAZ) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in RNAZ increasing?
Institutional interest in RNAZ can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related RNAZ Institutional Insights
- RNAZ Overview
- RNAZ 13F Institutional Holders
- RNAZ Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- RNAZ Insider Trading & SEC Form 4 Activity
- RNAZ Articles
- Top Institutional Investor Stock Rankings